Pathogen recognition and development of particulate vaccines: does size matter?

Area of Science:

• Vaccinology
• Immunology
• Nanotechnology

Background:

• Particulate carriers offer a promising avenue for creating effective and affordable recombinant vaccines.
• Understanding particle uptake and processing is crucial for designing vaccines that safely stimulate desired immune responses.

Purpose of the Study:

• To provide an overview of particulate vaccine formulations.
• To discuss cellular uptake mechanisms of pathogens and particles by antigen-presenting cells (APCs), particularly dendritic cells (DCs).
• To highlight the impact of particle characteristics on vaccine efficacy and immune responses.

Main Methods:

• Review of current particulate vaccine formulations and their characteristics.
• Discussion of cellular uptake mechanisms including endocytosis, macropinocytosis, phagocytosis, and clathrin/caveloae-mediated pathways.
• Analysis of antigen processing and presentation by APCs and DCs.

Main Results:

• Particle size and composition critically influence immune responses, including humoral and cellular immunity (CD4+ and CD8+ T cell activation).
• Recently developed "cutting edge" particulate vaccines utilize nano to micro-sized particles.
• Methods for formulation, production, affordability, reproducibility, and stability are presented.

Conclusions:

• Rational vaccine development necessitates a deep understanding of host-pathogen recognition and particle interactions with APCs.
• Particle characteristics are key determinants of vaccine efficacy, influencing the type and strength of the immune response.
• This work addresses practical, economic, and regulatory challenges in developing particulate vaccines for human and veterinary use.